Chemical formula: C₂₄H₂₆N₂O₄ Molecular mass: 406.474 g/mol PubChem compound: 2585
Carvedilol is a vasodilatory non-selective beta-blocker, which reduces the peripheral vascular resistance by selective alpha1-receptor blockade and suppresses the renin-angiotensin system through non-selective beta-blockade. Plasma renin activity is reduced and fluid retention is rare.
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C07AG02 | Carvedilol | C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AG Alpha and beta blocking agents |
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
| Title | Information Source | Document Type | |
|---|---|---|---|
| EUCARDIC Tablet | Health Products Regulatory Authority (IE) | MPI, EU: SmPC | |
| CARVEDILOL Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
| CARVEDILOL Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Carvedilol is an active ingredient of these brands:
Austria (AT)
Croatia (HR)Ecuador (EC)Estonia (EE)Finland (FI)France (FR)
Germany (DE)Ireland (IE)Israel (IL)Japan (JP)Mexico (MX)Nigeria (NG)Poland (PL)
South Africa (ZA)Spain (ES)
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide. |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
